Montreal-based content creator Zoe Morgan went from getting “stares of admiration” to “stares of contempt," she tells PEOPLE ...
“We are thrilled to reach this crucial milestone in our clinical program”, said Dr. Hermann Luebbert, CEO and Chairman of Biofrontera Inc. “The results of this Phase 2b study show promising reductions ...
Understanding the Testosterone-Acne Connection If you thought acne breakouts were only a teenage problem, think again.
The "Twisters" star reflected on having hormonal challenges as a teen, calling her diagnosis at age 24 “a relief" ...
(RTTNews) - Ascletis Pharma Inc. (HKEX: 1672) today announced positive topline results from its Phase 3 study for Denifanstat, a once-daily oral fatty acid synthase (FASN) inhibitor for ...
Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...
Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...
SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and ...
The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...
Transgender men have a higher acne risk compared with matched cisgender men and women, with the risk highest at 1 year after testosterone initiation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results